| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |